Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newer developments in immunohistology.

A S-Y Leong1, T Y-M Leong

  • 1Discipline of Anatomical Pathology, University of Newcastle, Newcastle, Australia. aleong@mail.newcastle.edu.au

Journal of Clinical Pathology
|October 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apoptosis is a major cause of so-called "caseous necrosis" in mycobacterial granulomas in HIV-infected patients.

Journal of clinical pathology·2007
Same author

FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma.

Journal of clinical pathology·2005
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026
Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026
Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026
Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026
See all related articles

Immunohistology, using advanced antibodies and antigen retrieval, aids cancer diagnosis and treatment selection. However, standardizing staining and quantification remains a challenge due to debated antigen retrieval mechanisms and lack of controls.

Area of Science:

  • Histopathology
  • Oncology
  • Molecular Biology

Background:

  • Immunohistology is crucial for cancer diagnosis, prognosis, and treatment selection.
  • Advancements in reagents, detection systems, and heat-induced antigen retrieval have enhanced its utility.
  • New antibodies offer potential for detecting genetic abnormalities and guiding targeted therapies.

Purpose of the Study:

  • To review the current state and future potential of immunohistology in cancer research and clinical practice.
  • To highlight the role of immunohistochemistry in identifying therapeutic targets for monoclonal antibody treatment.
  • To discuss challenges in standardization and quantification of immunostaining.

Main Methods:

  • Review of current literature on immunohistology techniques and applications.

Related Experiment Videos

  • Discussion of antibody development for genetic abnormality detection.
  • Analysis of antigen retrieval methods and their impact on standardization.

    • Main Results:

    • Immunohistology is indispensable for routine histology, aiding diagnosis and treatment.
    • Antibodies detecting genetic alterations and proliferation markers are vital for personalized cancer therapy.
    • The mechanism of antigen retrieval is still debated, impacting standardization.

    Conclusions:

    • Immunohistology is a powerful tool in oncology, with ongoing advancements.
    • Standardization and validation of immunostaining, particularly quantification, require further research.
    • Optimal controls and understanding antigen retrieval mechanisms are essential for reliable results.